Concepedia

Laura Deiana

LD

Statistics

Publications

1

Citations

21

H-Index

1

Active since

2025

Affiliations

BoRdeaux Institute of onCology(Current)

Laura Deiana is an author at BoRdeaux Institute of onCology specializing in chemotherapy, androgen therapy, and triple-negative breast cancer therapy.

ORCID

Publications per year

2025–2025

1

Publications

1

Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial

Hervé Bonnefoi, Florence Lerebours, Marina Pulido et al. · The Lancet Oncology · 2025 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

1–1 of 1